Ferrini, A;
Stevens, MM;
Sattler, S;
Rosenthal, N;
(2019)
Toward Regeneration of the Heart: Bioengineering Strategies for Immunomodulation.
Frontiers in Cardiovascular Medicine
, 6
, Article 26. 10.3389/fcvm.2019.00026.
Preview |
Text
fcvm-06-00026.pdf - Published Version Download (2MB) | Preview |
Abstract
Myocardial Infarction (MI) is the most common cardiovascular disease. An average-sized MI causes the loss of up to 1 billion cardiomyocytes and the adult heart lacks the capacity to replace them. Although post-MI treatment has dramatically improved survival rates over the last few decades, more than 20% of patients affected by MI will subsequently develop heart failure (HF), an incurable condition where the contracting myocardium is transformed into an akinetic, fibrotic scar, unable to meet the body's need for blood supply. Excessive inflammation and persistent immune auto-reactivity have been suggested to contribute to post-MI tissue damage and exacerbate HF development. Two newly emerging fields of biomedical research, immunomodulatory therapies and cardiac bioengineering, provide potential options to target the causative mechanisms underlying HF development. Combining these two fields to develop biomaterials for delivery of immunomodulatory bioactive molecules holds great promise for HF therapy. Specifically, minimally invasive delivery of injectable hydrogels, loaded with bioactive factors with angiogenic, proliferative, anti-apoptotic and immunomodulatory functions, is a promising route for influencing the cascade of immune events post-MI, preventing adverse left ventricular remodeling, and offering protection from early inflammation to fibrosis. Here we provide an updated overview on the main injectable hydrogel systems and bioactive factors that have been tested in animal models with promising results and discuss the challenges to be addressed for accelerating the development of these novel therapeutic strategies.
| Type: | Article |
|---|---|
| Title: | Toward Regeneration of the Heart: Bioengineering Strategies for Immunomodulation |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3389/fcvm.2019.00026 |
| Publisher version: | https://doi.org/10.3389/fcvm.2019.00026 |
| Language: | English |
| Additional information: | Copyright © 2019 Ferrini, Stevens, Sattler and Rosenthal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| Keywords: | myocardial infarction, injectable hydrogel, cardiac regeneration, immunomodulation, growth factors |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10119049 |
Archive Staff Only
 |
View Item |
